Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T12:11:27.739Z Has data issue: false hasContentIssue false
  • English
  • Français

Real-world continuous physiologic monitoring in paediatric cardiomyopathy patients: a safety and feasibility study

Published online by Cambridge University Press:  10 September 2019

Catherine A. Lebo ,
Kimberly Y. Lin  and
Joseph W. Rossano Open the ORCID record for Joseph W. Rossano [Opens in a new window]
Catherine A. Lebo
Affiliation:
Cardiac Center, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Kimberly Y. Lin
Affiliation:
Cardiac Center, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Joseph W. Rossano*
Affiliation:
Cardiac Center, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
*
Author for correspondence: J. W. Rossano, Department of Cardiology, Children’s Hospital of Philadelphia, 34th Street & Civic Center Boulevard, Philadelphia, PA 19104, USA. Tel: 215-590-4040; Fax: 267-426-9800; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Chronic disease management may be improved with the integration of mobile technologies capable of real-world physiologic monitoring. We performed a prospective, single-centre, pilot study to assess the feasibility of a consumer-based activity monitor use in outpatient management of adolescent cardiomyopathy patients. During the 3-month study period, the activity monitor was worn consistently and provided detailed physiologic and activity data with no adverse events related to the device use. Survey data revealed that the majority of subjects approve of these technologies becoming integrated into routine clinical care. Ongoing study is in need to define optimal disease management for this complex patient population in the age of consumer-driven healthcare.

Keywords

cardiomyopathymobile technologyactivity monitoring
Type
Brief Report
Information
Cardiology in the Young , Volume 29 , Issue 11 , November 2019 , pp. 1400 - 1401
Copyright
© Cambridge University Press 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Maron, BJ, Chaitman, BR, Ackerman, MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109: 2807–2816.CrossRefGoogle ScholarPubMed
Baggish, AL, Ackerman, MJ, Lampert, R. Competitive sport participation among athletes with heart disease: a call for a paradigm shift in decision making. Circulation 2017; 136: 1569–1571.CrossRefGoogle Scholar
Schuna, JM Jr., Johnson, WD, Tudor-Locke, C. Adult self-reported and objectively monitored physical activity and sedentary behavior: NHANES 2005–2006. Int J Behav Nutr Phys Act 2013; 10: 126.CrossRefGoogle ScholarPubMed
Kaiser, DW, Harrington, RA, Turakhia, MP. Wearable fitness trackers and heart disease. JAMA Cardiol 2016; 1: 239.CrossRefGoogle ScholarPubMed
Voss, C, Gardner, RF, Dean, PH, Harris, KC. Validity of commercial activity trackers in children with congenital heart disease. Can J Cardiol 2017; 33: 799–805.CrossRefGoogle ScholarPubMed
Brewer, W, Swanson, BT, Ortiz, A. Validity of Fitbit’s active minutes as compared with a research-grade accelerometer and self-reported measures. BMJ Open Sport Exerc Med 2017; 3: e000254.CrossRefGoogle ScholarPubMed